| Title: |
Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple Myeloma |
| Authors: |
Costa, Luciano J. 1, ⁎; Lin, Yi 2; Cornell, R. Frank 3, #; Martin, Thomas 4; Chhabra, Saurabh 5; Usmani, Saad Z. 6; Jagannath, Sundar 7; Callander, Natalie S. 8; Berdeja, Jesus G. 9; Kang, Yubin 10; Vij, Ravi 11; Godby, Kelly N. 1; Malek, Ehsan 12; Neppalli, Amarendra 13; Liedtke, Michaela 14; Fiala, Mark 11; Tian, Hong 15; Valluri, Satish 16; Marino, Jennifer 17; Jackson, Carolyn C. 15; Banerjee, Arnob 17; Kansagra, Ankit 18; Schecter, Jordan M. 15; Kumar, Shaji 2; Hari, Parameswaran 5 |
| Source: |
In Clinical Lymphoma, Myeloma and Leukemia May 2022 22(5):326-335 |
| Database: |
ScienceDirect |